Evommune, Inc. (EVMN)
NYSE: EVMN · CIK 0002044725 · United States
Every official Evommune, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open EVMN filings
Evommune, Inc. documents
- Evommune, Inc. 10-K 2026EVMN 10-K 2026: annual report for fiscal 2026
- Evommune, Inc. 10-K 2025EVMN 10-K 2025: annual report for fiscal 2025
- Evommune, Inc. 10-K 2024EVMN 10-K 2024: annual report for fiscal 2024
- Evommune, Inc. 10-K 2023EVMN 10-K 2023: annual report for fiscal 2023
- Evommune, Inc. 10-K 2022EVMN 10-K 2022: annual report for fiscal 2022
- Evommune, Inc. 10-Q 2026EVMN 10-Q 2026: quarterly report for fiscal 2026
- Evommune, Inc. 10-Q 2025EVMN 10-Q 2025: quarterly report for fiscal 2025
- Evommune, Inc. 10-Q 2024EVMN 10-Q 2024: quarterly report for fiscal 2024
- Evommune, Inc. 10-Q 2023EVMN 10-Q 2023: quarterly report for fiscal 2023
- Evommune, Inc. 10-Q 2022EVMN 10-Q 2022: quarterly report for fiscal 2022
- Evommune, Inc. 8-K 2026EVMN 8-K 2026: current report for fiscal 2026
- Evommune, Inc. 8-K 2025EVMN 8-K 2025: current report for fiscal 2025
- Evommune, Inc. 8-K 2024EVMN 8-K 2024: current report for fiscal 2024
- Evommune, Inc. 8-K 2023EVMN 8-K 2023: current report for fiscal 2023
- Evommune, Inc. 8-K 2022EVMN 8-K 2022: current report for fiscal 2022
- Evommune, Inc. DEF 14A 2026EVMN DEF 14A 2026: proxy statement for fiscal 2026
- Evommune, Inc. DEF 14A 2025EVMN DEF 14A 2025: proxy statement for fiscal 2025
- Evommune, Inc. DEF 14A 2024EVMN DEF 14A 2024: proxy statement for fiscal 2024
- Evommune, Inc. DEF 14A 2023EVMN DEF 14A 2023: proxy statement for fiscal 2023
- Evommune, Inc. DEF 14A 2022EVMN DEF 14A 2022: proxy statement for fiscal 2022
- Evommune, Inc. Form 4 2026EVMN Form 4 2026: insider trading filing for fiscal 2026
- Evommune, Inc. Form 4 2025EVMN Form 4 2025: insider trading filing for fiscal 2025
- Evommune, Inc. Form 4 2024EVMN Form 4 2024: insider trading filing for fiscal 2024
- Evommune, Inc. Form 4 2023EVMN Form 4 2023: insider trading filing for fiscal 2023
- Evommune, Inc. Form 4 2022EVMN Form 4 2022: insider trading filing for fiscal 2022
- Evommune, Inc. S-1 2026EVMN S-1 2026: registration statement for fiscal 2026
- Evommune, Inc. S-1 2025EVMN S-1 2025: registration statement for fiscal 2025
- Evommune, Inc. S-1 2024EVMN S-1 2024: registration statement for fiscal 2024
- Evommune, Inc. S-1 2023EVMN S-1 2023: registration statement for fiscal 2023
- Evommune, Inc. S-1 2022EVMN S-1 2022: registration statement for fiscal 2022
- Evommune, Inc. 13F 2026EVMN 13F 2026: institutional holdings for fiscal 2026
- Evommune, Inc. 13F 2025EVMN 13F 2025: institutional holdings for fiscal 2025
- Evommune, Inc. 13F 2024EVMN 13F 2024: institutional holdings for fiscal 2024
- Evommune, Inc. 13F 2023EVMN 13F 2023: institutional holdings for fiscal 2023
- Evommune, Inc. 13F 2022EVMN 13F 2022: institutional holdings for fiscal 2022
More companies